Insights into the history and trends of nanotechnology for the treatment of hepatocellular carcinoma: a bibliometric-based visual analysis

被引：0

作者：

Yulei Zhao ^{[1
]}

Xingxin Wang ^{[2
]}

Xiaoman Yang ^{[1
]}

Jiaheng Li ^{[3
]}

Bingbing Han ^{[1
]}

机构：

[1] College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Shandong, Jinan

[2] College of Acupuncture and Tuina, Shandong University of Traditional Chinese Medicine, Jinan

[3] College of Health, Shandong University of Traditional Chinese Medicine, Jinan

来源：

Discover Oncology | / 16卷 / 1期

关键词：

Bibliometrics; CiteSpace; Hepatocellular carcinoma; Nanotechnology; VOSviewer;

D O I：

10.1007/s12672-025-02145-7

中图分类号：

学科分类号：

摘要：

Background: Nanotechnology has great potential and advantages in the treatment of hepatocellular carcinoma (HCC), but the research trends and future directions are not yet clear. Objectives: Analyze the development trajectory, research hotspots, and future trends of nanotechnology and HCC research globally in the past 20 years, providing a more comprehensive and intuitive reference for researchers in this field. Methods: Retrieve relevant literature on nanotechnology and HCC research in the Web of Science (WOS) Core Collection database, and conduct bibliometric analysis using software such as CiteSpace, VOSviewer, and SCImago Graphica. Results: A total of 852 English publications meeting the criteria were retrieved from the WOS database, with an overall increasing trend in the number of publications and citation frequency over the years. China leads in the number of publications and international collaborations, followed by the USA and India. The most influential research institution is the Chinese Academy of Sciences, the most influential scholar/team is the Rahman, Mahfoozur team, and the journal with the most publications is the International Journal of Nanomedicine. A comprehensive analysis reveals that the current main research directions include new types of nanoparticles, targeted drug delivery systems, photothermal/photodynamic therapy, gene delivery systems, diagnostics, and imaging. It is anticipated that further collaboration among scholars, institutions, and countries will accelerate the development of nanotechnology in the field of HCC research. Conclusion: This study provides an in-depth analysis of the research status and development trends of nanotechnology in treating HCC from a bibliometric perspective, offering possible guidance for researchers to explore hot topics and frontiers, select suitable journals, and partners in this field. © The Author(s) 2025.

引用

共 131 条

[51]

Xue H., Yu Z., Liu Y., Yuan W., Yang T., You J., He X., Lee R.J., Li L., Xu C., Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma, Int J Nanomed, 12, pp. 5271-5287, (2017)

[52]

Yang Z., Duan J., Wang J., Liu Q., Shang R., Yang X., Lu P., Xia C., Wang L., Dou K., Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy, Int J Nanomed, 13, pp. 1851-1865, (2018)

[53]

Zhang H., Zheng D., Ding J., Xu H., Li X., Sun W., Efficient delivery of ursolic acid by poly(N-vinylpyrrolidone)-block-poly (ε-caprolactone) nanoparticles for inhibiting the growth of hepatocellular carcinoma in vitro and in vivo, Int J Nanomed, 10, pp. 1909-1920, (2015)

[54]

Hefnawy A., Khalil I.H., Arafa K., Emara M., El-Sherbiny I.M., Dual-ligand functionalized core-shell chitosan-based nanocarrier for hepatocellular carcinoma-targeted drug delivery, Int J Nanomed, 15, pp. 821-837, (2020)

[55]

Huang Y., Hu L., Huang S., Xu W., Wan J., Wang D., Zheng G., Xia Z., Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration, Int J Nanomed, 13, pp. 8309-8323, (2018)

[56]

Xiang G.H., Hong G.B., Wang Y., Cheng D., Zhou J.X., Shuai X.T., Effect of PEG-PDLLA polymeric nanovesicles loaded with doxorubicin and hematoporphyrin monomethyl ether on human hepatocellular carcinoma HepG2 cells in vitro, Int J Nanomed, 8, pp. 4613-4622, (2013)

[57]

Zhang Y., Xie F., Yin Y., Zhang Q., Jin H., Wu Y., Pang L., Li J., Gao J., Immunotherapy of tumor RNA-loaded lipid nanoparticles against hepatocellular carcinoma, Int J Nanomed, 16, pp. 1553-1564, (2021)

[58]

Zu Y., Meng L., Zhao X., Ge Y., Yu X., Zhang Y., Deng Y., Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery, Int J Nanomed, 8, pp. 1207-1222, (2013)

[59]

Chen Y., Wu B., Shang H., Sun Y., Tian H., Yang H., Wang C., Wang X., Cheng W., Sono-immunotherapy mediated controllable composite nano fluorescent probes reprogram the immune microenvironment of hepatocellular carcinoma, Int J Nanomed, 18, pp. 6059-6073, (2023)

[60]

Zhu J., Li Y., Li L., Wang J., Wang H., Hong W., Hao K., Xue Y., Chen B., Wang Z., A novel absorption spectrometric method, based on graphene nanomaterials, for detection of hepatocellular carcinoma-specific T lymphocyte cells, Int J Nanomed, 13, pp. 5523-5536, (2018)

← 1 2 3 4 5 6 7 8 9 10 →